Quarterly report · Q1
2590.TEDINET S100QVFN
Period2023-01-21 → 2023-04-20
Filed2023-06-02
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.1bn | 2023-01-21 → 2023-04-20 | Cons. | Net sales |
| Revenue | ¥160.1bn | 2022-01-21 → 2023-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥34.9bn | 2022-01-21 → 2022-04-20 | Cons. | Net sales |
| Operating income | −¥539m | 2023-01-21 → 2023-04-20 | Cons. | Operating income |
| Operating income | −¥986m | 2022-01-21 → 2022-04-20 | Cons. | Operating income |
| Ordinary income | −¥442m | 2023-01-21 → 2023-04-20 | Cons. | Ordinary income |
| Ordinary income | ¥591m | 2022-01-21 → 2023-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2022-01-21 → 2022-04-20 | Cons. | Ordinary income |
| Profit before tax | −¥87m | 2023-01-21 → 2023-04-20 | Cons. | Income before income taxes |
| Profit before tax | −¥1.2bn | 2022-01-21 → 2022-04-20 | Cons. | Income before income taxes |
| Net income (owners) | −¥296m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥507m | 2022-01-21 → 2023-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.6bn | 2022-01-21 → 2022-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥299m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss |
| Net income | −¥1.6bn | 2022-01-21 → 2022-04-20 | Cons. | Profit loss |
| Total assets | ¥179.1bn | at 2023-04-20 | Cons. | Assets |
| Total assets | ¥164.2bn | at 2023-01-20 | Cons. | Assets |
| Total assets | ¥165.3bn | at 2022-04-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥90.6bn | at 2023-04-20 | Cons. | Liabilities |
| Total liabilities | ¥80.1bn | at 2023-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥88.5bn | at 2023-04-20 | Cons. | Net assets |
| Net assets / equity | ¥84.1bn | at 2023-01-20 | Cons. | Net assets |
| Net assets / equity | ¥83.0bn | at 2022-04-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.2bn | at 2023-04-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.2bn | at 2023-01-20 | Cons. | Cash and deposits |
| EPS (basic) | ¥-18.9 | 2023-01-21 → 2023-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.4 | 2022-01-21 → 2023-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-99.09 | 2022-01-21 → 2022-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 48.4% | at 2023-04-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.9% | at 2023-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.9% | at 2022-04-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | segment profit | 2023-01-21 → 2023-04-20 | −¥151m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥238m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥133m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥84m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥63m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| —segment total | revenue | 2023-01-21 → 2023-04-20 | ¥47.2bn |
| —segment total | revenue external | 2023-01-21 → 2023-04-20 | ¥47.1bn |
| —segment total | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥77m |
| —segment total | segment profit | 2023-01-21 → 2023-04-20 | −¥387m |
| Reconciling Itemsreconciling | revenue | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | segment profit | 2022-01-21 → 2022-04-20 | −¥270m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥325m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥96m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | ¥234m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥3.1bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥3.1bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥499m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥2.9bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥2.7bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥120m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥28m |
| —segment total | revenue | 2022-01-21 → 2022-04-20 | ¥35.0bn |
| —segment total | revenue external | 2022-01-21 → 2022-04-20 | ¥34.9bn |
| —segment total | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥134m |
| —segment total | segment profit | 2022-01-21 → 2022-04-20 | −¥715m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 393
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 24773000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 3108000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 2851000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 4312000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 35046000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -134000000 | JPY |
| Net sales | Prior1YTDDuration | 34912000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | -325000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | -499000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | -28000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 234000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | -96000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | -715000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -270000000 | JPY |
| Operating income | Prior1YTDDuration | -986000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 34716000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 5286000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 2972000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 4126000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 47102000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 47102000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 12000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 63000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 77000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -77000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 34728000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 5286000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 3035000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 4128000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 47179000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -77000000 | JPY |
| Net sales | CurrentYTDDuration | 47102000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | -238000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | -84000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 34000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 34000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | -133000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | -387000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -151000000 | JPY |
| Operating income | CurrentYTDDuration | -539000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |